APA (7th ed.) Citation

EJ, L., F, S. H., H, T., D, S., PA, A., L, M., . . . GV, L. (2025). Nivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year update. European journal of cancer (Oxford, England : 1990), 225, 115547. https://doi.org/10.1016/j.ejca.2025.115547

Chicago Style (17th ed.) Citation

EJ, Lipson, et al. "Nivolumab Plus Relatlimab in Advanced Melanoma: RELATIVITY-047 4-year Update." European Journal of Cancer (Oxford, England : 1990) 225 (2025): 115547. https://doi.org/10.1016/j.ejca.2025.115547.

MLA (9th ed.) Citation

EJ, Lipson, et al. "Nivolumab Plus Relatlimab in Advanced Melanoma: RELATIVITY-047 4-year Update." European Journal of Cancer (Oxford, England : 1990), vol. 225, 2025, p. 115547, https://doi.org/10.1016/j.ejca.2025.115547.